share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:拟议出售证券
美股sec公告 ·  06/25 16:26
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares of the company on 06/25/2024, as per the latest filing. The shares, valued at approximately $108,805.92, were originally acquired as founders shares on 09/01/2016 as part of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 77,289 shares were sold for gross proceeds of $684,271.04. The notice of the upcoming sale was filed on the same date as the planned sale, with the instruction for this transaction given on 08/18/2023.
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares of the company on 06/25/2024, as per the latest filing. The shares, valued at approximately $108,805.92, were originally acquired as founders shares on 09/01/2016 as part of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 77,289 shares were sold for gross proceeds of $684,271.04. The notice of the upcoming sale was filed on the same date as the planned sale, with the instruction for this transaction given on 08/18/2023.
Recursion Pharmaceuticals药品公司董事Blake Borgeson计划于06/25/2024出售11,447股A类股份,根据最新申报。这些股份约价值$108,805.92,最初是作为奖励发行方股份于09/01/2016获得的。这次拟定销售计划是在过去三个月中一系列交易的基础上制定的,共售出77,289股,总收益为$684,271.04。计划销售的通知文件是在同一日期提交的,此次交易的操作说明为08/18/2023。
Recursion Pharmaceuticals药品公司董事Blake Borgeson计划于06/25/2024出售11,447股A类股份,根据最新申报。这些股份约价值$108,805.92,最初是作为奖励发行方股份于09/01/2016获得的。这次拟定销售计划是在过去三个月中一系列交易的基础上制定的,共售出77,289股,总收益为$684,271.04。计划销售的通知文件是在同一日期提交的,此次交易的操作说明为08/18/2023。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息